EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean

Philipp Rausch iD, Sarah Ellul, Anthea Pisani iD, Corinna Bang, Trevor Tabone, Claire Marantidis Cordina, Graziella Zahra, Andre Franke, Pierre Ellul

Inflammatory Bowel Diseases · 2023

DOI: 10.1093/ibd/izad004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2023. Verfasst von Philipp Rausch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Crohn Disease, Colitis, Ulcerative, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microbial communities have long been suspected to influence inflammatory processes in the gastrointestinal tract of patients with inflammatory bowel disease. However, these effects are often influenced by treatments and can rarely be analyzed in treatment-naïve onset cases. Specifically, microbial differences between IBD pathologies in new onset cases have rarely been investigated and can provide novel insight into the dynamics of the microbiota in Crohn’s disease (CD) and ulcerative colitis (UC).

Methods

Fifty-six treatment-naïve IBD onset patients (67.3% CD, 32.7% UC) and 97 healthy controls were recruited from the Maltese population. Stool samples were collected after diagnosis but before administration of anti-inflammatory treatments. Fecal microbial communities were assessed via 16S rRNA gene sequencing and subjected to ecological analyses to determine disease-specific differences between pathologies and disease subtypes or to predict future treatment options.

Results

We identified significant differences in community composition, variability, and diversity between healthy and diseased individuals—but only small to no differences between the newly diagnosed, treatment-naïve UC and CD cohorts. Network analyses revealed massive turnover of bacterial interactions between healthy and diseased communities, as well as between CD and UC communities, as signs of disease-specific changes of community dynamics. Furthermore, we identified taxa and community characteristics serving as predictors for prospective treatments.

Conclusion

Untreated and newly diagnosed IBD shows clear differences from healthy microbial communities and an elevated level of disturbance, but only the network perspective revealed differences between pathologies. Furthermore, future IBD treatment is to some extent predictable by microbial community characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeCrohn DiseaseColitis, UlcerativeInflammatory Bowel DiseasesHumansRNA, Ribosomal, 16SFeces

Stichwörter der Autor:innen

Crohn’s diseasebiomarkerinflammatory bowel diseasemicrobiometreatment naïvetreatment predictionulcerative colitis

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Laboratory of Genomics and Molecular Biomedicine, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Division of Pediatric Surgery, Department of Surgery, Mater Dei Hospital, Malta.
  • Division of Gastroenterology, Department of Medicine, Mater Dei Hospital, Malta.
  • Department of Microbiology, Mater Dei Hospital, Malta.
  • Molecular Diagnostics, Department of Pathology, Mater Dei Hospital, Malta.

ORCID-Profile: Philipp Rausch, Anthea Pisani

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Rausch, P., Ellul, S., Pisani, A., Bang, C., Tabone, T., Marantidis Cordina, C., Zahra, G., Franke, A., & Ellul, P. (2023). Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad004

Vancouver

Rausch P, Ellul S, Pisani A, Bang C, Tabone T, Marantidis Cordina C, et al. Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean. Inflammatory Bowel Diseases. 2023. doi:10.1093/ibd/izad004

BibTeX
@article{Rausch2023,
  author = {Rausch, Philipp and Ellul, Sarah and Pisani, Anthea and Bang, Corinna and Tabone, Trevor and Marantidis Cordina, Claire and Zahra, Graziella and Franke, Andre and Ellul, Pierre},
  title = {Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean},
  journal = {Inflammatory Bowel Diseases},
  year = {2023},
  doi = {10.1093/ibd/izad004}
}
Kostenlos starten →